Clinical trial
Intracuff Dexmedetomidine Versus Alkalinized Lidocaine for Reducing Peri-Extubation Cough and Hemodynamic Responses in Elderly Patients: A Randomized Double-Blind Controlled Trial
NCT07916246 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intracuff Dexmedetomidine Versus Alkalinized Lidocaine for Reducing Peri-Extubation Cough and Hemodynamic Responses in Elderly Patients: A Randomized Double-Blind Controlled Trial
- Lead sponsor
- Beni-Suef University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- May 31, 2027
- Enrollment
- 184 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
airway complication of anesthesia, emergence delirium, anesthesia, hemodynamic instability, postoperative complications
Arms
As registered; 2 arms.
-
Group DEX (Intracuff Dexmedetomidine)
Elderly surgical patients whose endotracheal tube (ETT) cuff is filled with a dexmedetomidine solution (16 µg total dose in 4 mL normal saline) immediately following tracheal intubation. Cuff pressure is maintained at 20-25 cmH2O throughout the surgery.
-
Group LIDO (Intracuff Alkalinized Lidocaine)
Elderly surgical patients whose endotracheal tube (ETT) cuff is filled with an alkalinized lidocaine solution (40 mg lidocaine + 8.4% sodium bicarbonate, total volume 4 mL) immediately following tracheal intubation. Cuff pressure is maintained at 20-25 cmH2O throughout the surgery.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Incidence of Smooth Extubation
Proportion (percentage) of participants in each group achieving smooth extubation, defined as a cough score of 0 or 1 on a validated 4-point scale during the first 60 seconds after tube removal. Assessment begins continuously at the exact moment the endotracheal tube cuff passes through the vocal cords (marked by stopwatch).
Cough Scale:
* 0 = No cough
* 1 = Single mild cough
* 2 = Moderate coughing (2-3 coughs)
* 3 = Severe coughing (≥4 coughs or bucking)A score of 0-1 indicates smooth extubation (desirable outcome).
Lead sponsor's other trials
Beni-Suef University, most recent start first.
+343 more trials See the organization page
Similar trials
Same condition (Emergence Delirium) and phase, most recent start first.
+288 more trials See the condition page